GUSB

Chr 7AR

glucuronidase beta

Also known as: BG, MPS7

The encoded hydrolase degrades glycosaminoglycans including heparan sulfate, dermatan sulfate, and chondroitin-4,6-sulfate within lysosomes as a homotetramer. Mutations cause mucopolysaccharidosis type VII (Sly syndrome) through autosomal recessive inheritance. Pathogenicity results from dominant-negative effects where mutant enzyme subunits disrupt normal tetramer function.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismARLOEUF 0.751 OMIM phenotype
Clinical SummaryGUSB
🧬
Gene-Disease Validity (ClinGen)
mucopolysaccharidosis type 7 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
53 unique Pathogenic / Likely Pathogenic· 103 VUS of 400 total submissions
📖
GeneReview available — GUSB
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.75LOEUF
pLI 0.000
Z-score 2.71
OE 0.51 (0.350.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.10Z-score
OE missense 0.84 (0.770.92)
315 obs / 374.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.51 (0.350.75)
00.351.4
Missense OE0.84 (0.770.92)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 18 / 35.4Missense obs/exp: 315 / 374.9Syn Z: -0.80
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGUSB-related mucopolysaccharidosisLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7228th %ile
GOF
0.6248th %ile
LOF
0.2483th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic33
Likely Pathogenic20
VUS103
Likely Benign227
Benign3
Conflicting3
33
Pathogenic
20
Likely Pathogenic
103
VUS
227
Likely Benign
3
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
30
1
2
0
33
Likely Pathogenic
17
3
0
0
20
VUS
3
94
6
0
103
Likely Benign
0
5
89
133
227
Benign
0
0
3
0
3
Conflicting
3
Total50103100133389

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GUSB · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →